ReadyCell News
Stay up-to-date on the latest ReadyCell news, projects and developments.
StretchBio holds its 18-month meeting
Our representatives participated in the 18-month meeting of the StretchBio project, held in Freiburg. The meeting was focused on the design and operation of the functional prototype of the sensor.
Happy International Women’s Day!
With this infographic, we proudly show the key facts we have achieved in recent times in promoting gender equality and women’s rights in the company.
Toxicological evaluation of chemicals and the implications of human P-gp and BCRP transporters
Publications have confirmed the importance of developing safe chemical agents using membrane transporter analysis as a criterion. This is reflected in the field of pesticides, one of the areas in which this analysis has been most widely applied.
3DLIVER: Innovative Human-Derived 3D Liver Models for Drug Toxicity Testing and Discovery
The main objective of this project is to develop novel 3D in vitro tools derived from the human liver, relevant to the discovery and preclinical phases of drug development.
Caco-2 based in vitro models for the screening of anti-inflammatory drugs
Inflammatory reactions of the intestinal tract are the result of a combination of hereditary, genetic and/or environmental factors that have been clustered in the inflammatory bowel disease (IBD). ReadyCell has available CacoReady and CacoGoblet to assay compounds inflammatory properties.
CacoReady permeability test, used to study a novel treatment against malignant cells
A new drug against malignant cells was found using methods such as High Throughput Screening (HTS) and Caco-2 permeability assay with CacoReady plates.
Happy Holiday Season from ReadyCell!
We want to send you our greetings and best wishes for the holiday season! This year, artists from the art studio of the AMPANS Foundation created a special Christmas card.
ReadyCell is attending the 7th Annual Drug Discovery Summit
The Drug Discovery Summit (DDS) includes high-level national and international speakers, interactive roundtables, knowledge-sharing panel sessions, workshops and networking.
Adari Cell visits ReadyCell’s facilities in Barcelona
The U.S. company Adari Cell Science met with ReadyCell at the Parc Científic de Barcelona and shared their impressions of the past year.
Play with us in the Science Week!
ReadyCell wants to contribute to the knowledge of science through scientific divulgation and didactics. For this purpose, we have prepared some games with scientific concepts to better understand processes.
ReadyCell has been accepted into the ICEX Next Program
ReadyCell SL in the context of the ICEX Next Program, has been supported by ICEX and co-financed by the European FEDER fund. The purpose of this support is to contribute to the international development of the company and its environment.
Cancer drug development: what to know about ABC transporters
The presence of the superfamily members of the ATP binding cassette (ABC) transporters is well established as the main cause of multidrug resistance, since they efflux therapeutic compounds from cells and reduce the intracellular drug levels.
Stretchbio holds a meeting in Denmark to evaluate the first 12 months of the project
Readycell participated in the annual meeting of the StretchBio Project, which was held at the Danmarks Tekniske Universitet (DTU) in Copenhagen.
A new study uses CacoGoblet in a gut-liver-organ-on-a-chip
An investigation led by the researcher Nicoló Milani was published in the prestigious analytical journal Lab on a Chip. The CacoGoblet kit was employed to investigate the permeability and the metabolism of the compound in a gut-liver-organ-on-a-chip (OoC).